Evidence map›Paper›PMID 26866596›Full record

ArticleACS applied materials & interfaces2016

Nanotopography-Induced Structural Anisotropy and Sarcomere Development in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells.

Daniel Carson, Marketa Hnilova, Xiulan Yang, Cameron L Nemeth, Jonathan H Tsui, Alec S T Smith, Alex Jiao, Michael Regnier, Charles E Murry, Candan Tamerler and 1 more

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Cardiac maturation.Journal of molecular and cellular cardiology · 2024
    Review
  18. Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel Carson
Marketa Hnilova
Xiulan Yang
Cameron L Nemeth
Jonathan H Tsui
Alec S T Smith
Alex Jiao
Michael Regnier
Charles E Murry
Candan TamerlerDepartment of Mechanical Engineering and Bioengineering Research Center, University of Kansas , Lawrence, Kansas 66045, United States.
Deok-Ho Kim

Funding

Self Renewal and Differentiation of Human Embryonic Stem CellsP01GM081619 · NIGMS · UNIVERSITY OF WASHINGTON · PI REH, THOMAS A · 2007 to 2017
$20.6M
Vascularization and Growth of Human Myocardial GraftsP01HL094374 · NHLBI · UNIVERSITY OF WASHINGTON · PI MINAMI, ELINA · 2010 to 2014
$14.5M
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASET32HL007312 · NHLBI · UNIVERSITY OF WASHINGTON · PI MAJESKY, MARK W., SCHWARTZ, STEPHEN MARK · 1985 to 2019
$11.8M
Expansion of cardiac and hematopoietic progenitors by Wnt and NotchU01HL100405 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI EPSTEIN, JONATHAN A., MORRISEY, EDWARD E · 2009 to 2015
$8.1M
Cell-Based Cardiac RepairR01HL084642 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E · 2007 to 2014
$4.9M
Genetic and Molecular Basis of Congenital ContracturesR01HD048895 · NICHD · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH · 2005 to 2016
$4.3M
Bioengineering Cardiovascular Training GrantT32EB001650 · NIBIB · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2004 to 2019
$3.6M
EFFECT OF R1R2 OVER-EXPRESSION ON CARDIAC FUNCTIONR01HL111197 · NHLBI · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2012 to 2015
$2.3M
Peptide Enabled Self Assembled Reconfigurable Implant CoatingsR21AR062249 · NIAMS · UNIVERSITY OF WASHINGTON · PI TAMERLER-BEHAR, CANDAN · 2012 to 2013
$363k
National Institute of Health T32 2T32HL007312-36AINHLBI NIH HHS P01 HL094374NHLBI NIH HHS R01 HL084642NHLBI NIH HHS R01 HL111197NHLBI NIH HHS T32 HL007312NHLBI NIH HHS U01 HL100405NIAMS NIH HHS AR062249-03NIAMS NIH HHS R21 AR062249NIBIB NIH HHS T32 EB001650NICHD NIH HHS R01 HD048895NIGMS NIH HHS P01 GM081619
6 · The paper itself

Abstract

Understanding the phenotypic development of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) is a prerequisite to advancing regenerative cardiac therapy, disease modeling, and drug screening applications. Lack of consistent hiPSC-CM in vitro data can be largely attributed to the inability of conventional culture methods to mimic the structural, biochemical, and mechanical aspects of the myocardial niche accurately. Here, we present a nanogrid culture array comprised of nanogrooved topographies, with groove widths ranging from 350 to 2000 nm, to study the effect of different nanoscale structures on the structural development of hiPSC-CMs in vitro. Nanotopographies were designed to have a biomimetic interface, based on observations of the oriented myocardial extracellular matrix (ECM) fibers found in vivo. Nanotopographic substrates were integrated with a self-assembling chimeric peptide containing the Arg-Gly-Asp (RGD) cell adhesion motif. Using this platform, cell adhesion to peptide-coated substrates was found to be comparable to that of conventional fibronectin-coated surfaces. Cardiomyocyte organization and structural development were found to be dependent on the nanotopographical feature size in a biphasic manner, with improved development achieved on grooves in the 700-1000 nm range. These findings highlight the capability of surface-functionalized, bioinspired substrates to influence cardiomyocyte development, and the capacity for such platforms to serve as a versatile assay for investigating the role of topographical guidance cues on cell behavior. Such substrates could potentially create more physiologically relevant in vitro cardiac tissues for future drug screening and disease modeling studies.

Indexed as

Myocytes, CardiacAnisotropyCell DifferentiationHumansInduced Pluripotent Stem CellsNanostructuresOligopeptidesSarcomeresarginyl-glycyl-aspartic acidOligopeptidesbiomimetic surfacecardiomyocyteschimeric self-assembling peptidehuman induced pluripotent stem cellsnanotopography

Identifiers

PMID26866596
PMCPMC5681855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.